• Lies Langouche and Greet Van den Berghe.
• Laboratory and Department of Intensive Care Medicine, University of Leuven, Leuven, Belgium. Electronic address: lies.langouche@med.kuleuven.be.
• Handb Clin Neurol. 2014 Jan 1; 124: 115-26.

AbstractIndependent of the underlying condition, critical illness is characterized by a uniform dysregulation of the hypothalamic-pituitary-peripheral axes. In most axes a clear biphasic pattern can be distinguished. The acute phase of critical illness is characterized by low peripheral effector hormone levels such as T3, IGF-1 and testosterone, despite an actively secreting pituitary. The adrenal axis with high cortisol levels in the presence of low ACTH levels is a noteworthy exception. In the prolonged phase of critical illness, low peripheral effector hormone levels coincide with a uniform suppression of the neuroendocrine axes, predominantly of hypothalamic origin. The severity of the alterations in the different neuroendocrine axes is associated with a high risk of morbidity and mortality, but it remains unknown whether the observed changes are cause or consequence of adverse outcome. Several studies have identified therapeutic potential of hypothalamic releasing factors, but clinical outcome remains to be investigated with sufficiently powered randomized controlled trials. © 2014 Elsevier B.V. All rights reserved.

21 keywords...

hide…